Related Experiment Video
Updated: Jul 23, 2025
Quantitation of Rabies Virus in Various Bovine Brain Structures
Published on: May 22, 2021
Molecular Methods for Diagnosis of Monkeypox: A Mini-review
Rodrigo Michelini de Oliveira Thomasi1, Thais da Silva Correa1, Dalise Silva do Carmo1
1Disciplina Biotecnologia e Inovações, Programa de Pós-graduação em Biotecnologia e Programa Multicentrico de Pós-graduação em Bíoquimica e Biologia Molecular, Universidade Federal de São João Del- Rei, Divinópolis, 35501-296, MG, Brazil.
Background:
Monkeypox is a global public health issue caused by the monkeypox virus (MPXV). As of October 28, 2022, a total of 77,115 laboratoryconfirmed cases and 3,610 probable cases, including 36 deaths, were reported, with 9,070 cases reported in Brazil, the second most affected country. The need to develop national technologies for the rapid diagnosis of emerging diseases for mass testing of the population is evident, as observed in the SARS-CoV-2 pandemic.
Objective:
With that in mind, this article provides an overview of current methods, techniques, and their applications in the molecular detection of monkeypox, focusing the search on real-time polymerase chain reaction (qPCR), polymerase chain reaction (PCR), and polymerase chain reaction-enzyme linked immunosorbent assay (PCRELISA).
Methods:
The relevant documents or papers covered in this study were selected by a search in international bibliographic databases. The search terms used in the databases were aimed at summarizing existing knowledge on molecular diagnostic methods, such as monkeypox; MPX, MPXV, qPCR, PCR, PCR-ELISA, diagnosis and detection searched separately or together using the Boolean operator "AND" either in the title or abstract. The searches took place in September 2022, and the corresponding articles were selected between 2012 and 2022.
Results:
We found 256 documents in total and twelve studies addressing the molecular diagnosis of monkeypox were classified as possible sources for this review.
Conclusion:
It is evident there is a pressing need to develop national technologies for rapid diagnosis of emerging diseases for mass testing of the population. It is also extremely important to have national detection kits with greater diagnostic capacity to assist in developing effective public policies in countries affected by this disease.
